Trabectedin - Latest Advances

Targeted and molecular therapies in Ewing sarcoma: a comprehensive review of preclinical and clinical advances.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 03, 2026

Dynamic regulation of endogenous transcription factor hubs at single-molecule resolution.

Journal: bioRxiv : the preprint server for biology

Published: February 09, 2026

Efficacy and safety of trabectedin and pegylated liposomal doxorubicin in elderly patients: a subgroup analysis of a retrospective cohort.

Journal: Journal of chemotherapy (Florence, Italy)

Published: January 23, 2026

Schlafen 11 as a prognostic and potentially predictive biomarker in soft tissue sarcoma: evidence from a real-world cohort.

Journal: Frontiers in oncology

Published: January 20, 2026

Acute myocardial infarction caused by coronary tumor embolism from uterine leiomyosarcoma: a case report.

Journal: Gynecologic oncology reports

Published: January 14, 2026

Characterisation of Bespoke Patient-Derived In Vitro Models of Ewing Sarcoma.

Journal: Cancers

Published: December 18, 2025

First-Line Chemotherapy Regimens for Advanced and Metastatic Leiomyosarcoma: Doxorubicin vs. Gemcitabine-A Systematic Review.

Journal: Cancers

Published: December 16, 2025

DCMiC: a double-cylinder micro-chamber platform for high-throughput drug screening and modeling of microenvironmental resistance in Ewing sarcoma.

Journal: Lab on a chip

Published: December 09, 2025

Trabectedin-irinotecan as a potential therapeutic option in desmoplastic small round cell tumor: A small case series.

Journal: Tumori

Published: November 10, 2025

Marine-Derived Anticancer Compounds and their Clinical Status.

Journal: Anti-cancer agents in medicinal chemistry

Published: October 17, 2025

Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression.

Journal: Molecular therapy. Oncology

Published: October 15, 2025

Bidirectional Regulation in the Tumour Microenvironment: The Interaction Between Tumour-Associated Macrophages and T Cells Reshapes the Paradigm of Cancer Immunotherapy.

Journal: Immunology

Published: October 02, 2025